Stock Earnings

Question 1

Quels sont les états financiers clés de Arcturus Therapeutics Holdings Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Arcturus Therapeutics Holdings Inc a un total d'actifs de $344, un bénéfice net loss de $-80

Question 2

Quels sont les ratios financiers clés pour ARCT ?

Accepted Answer

Le ratio de liquidité de Arcturus Therapeutics Holdings Inc est 3.33, la marge nette est -52.63, les ventes par action sont de $5.62.

Question 3

Comment les revenus de Arcturus Therapeutics Holdings Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Arcturus Therapeutics Holdings Inc largest revenue segment is Messenger Ribonucleic Acid Medicines, at a revenue of 152,310,000 in the most earnings release.For geography, United States is the primary market for Arcturus Therapeutics Holdings Inc, at a revenue of 152,310,000.

Question 4

Arcturus Therapeutics Holdings Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Arcturus Therapeutics Holdings Inc a un bénéfice net loss de $-80

Question 5

Arcturus Therapeutics Holdings Inc a-t-elle des passifs ?

Accepted Answer

yes, Arcturus Therapeutics Holdings Inc a un passif de 103

Question 6

Combien d'actions en circulation Arcturus Therapeutics Holdings Inc a-t-elle ?

Accepted Answer

Arcturus Therapeutics Holdings Inc a un total d'actions en circulation de 27

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	97	152	166	206	12	9
Revenue Growth (YoY)	-39%	-8%	-19%	1,617%	33%	-55%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	44	52	52	46	41	23
Research & Development	131	195	192	147	173	57
Operating Expenses	175	247	245	193	215	81
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-66	-80	-27	10	-203	-72
Income Tax Expense	--	0	1	1	--	--
Net Income	-66	-80	-29	9	-203	-72
Net Income Growth	6%	176%	-422%	-104%	182%	177%
Shares Outstanding (Diluted)	27.18	27	26.62	27.1	26.3	20.3
Shares Change (YoY)	0%	1%	-2%	3%	30%	68%
EPS (Diluted)	-2.45	-2.99	-1.11	0.35	-7.74	-3.55
EPS Growth	6%	169%	-419%	-105%	118%	65%
Free Cash Flow	-58	-60	-21	24	-138	-44
Free Cash Flow Per Share	-2.13	-2.22	-0.78	0.88	-5.24	-2.16
Gross Margin	--	--	--	--	--	--
Operating Margin	-80.41%	-62.5%	-46.98%	5.82%	-1,683.33%	-788.88%
Profit Margin	-68.04%	-52.63%	-17.46%	4.36%	-1,691.66%	-800%
Free Cash Flow Margin	-59.79%	-39.47%	-12.65%	11.65%	-1,150%	-488.88%
EBITDA	-75	-92	-76	13	-201	-71
EBITDA Margin	-77.31%	-60.52%	-45.78%	6.31%	-1,675%	-788.88%
D&A For EBITDA	3	3	2	1	1	0
EBIT	-78	-95	-78	12	-202	-71
EBIT Margin	-80.41%	-62.5%	-46.98%	5.82%	-1,683.33%	-788.88%
Effective Tax Rate	--	0%	-3.7%	10%	--	--

Arcturus Therapeutics Holdings Inc (ARCT) Price

ARCT Stock Price Chart

ARCT Income

Follow-Up Questions